Legacy Capital Group California, Inc. Amicus Therapeutics, Inc. Transaction History
Legacy Capital Group California, Inc.
- $301 Billion
- Q3 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Amicus Therapeutics, Inc. stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 19,329 shares of FOLD stock, worth $224,023. This represents 0.07% of its overall portfolio holdings.
Number of Shares
19,329Holding current value
$224,023% of portfolio
0.07%Shares
1 transactions
Others Institutions Holding FOLD
# of Institutions
282Shares Held
325MCall Options Held
260KPut Options Held
261K-
Vanguard Group Inc Valley Forge, PA28.6MShares$331 Million0.01% of portfolio
-
Perceptive Advisors LLC New York, NY28.1MShares$325 Million8.05% of portfolio
-
Avoro Capital Advisors LLC New York, NY27.4MShares$318 Million3.71% of portfolio
-
Black Rock Inc. New York, NY24.4MShares$282 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA21.1MShares$245 Million0.04% of portfolio
About AMICUS THERAPEUTICS, INC.
- Ticker FOLD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 280,497,984
- Market Cap $3.25B
- Description
- Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant bas...